Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 12:05 PM ET

Life Sciences Tools and Services

Company Overview of SomaLogic, Inc.

Company Overview

SomaLogic, Inc. discovers, develops, and commercializes life science research tools and clinical diagnostic products for biological and medical science applications. It offers SOMAMER REAGENT, a proteomic platform that combines the properties of antibodies and aptamers; and SOMAscan assay, a protein biomarker discovery and development tool for protein measurement solutions. The company also provides diagnostic tests for various diseases and conditions. In addition, it offers protein-measurement assays, kits, and reagents for life science and biopharma researchers. Further, the company also provides protein biomarker-based diagnostics; and chemical reagents as potential therapeutic molecules....

2945 Wilderness Place

Boulder, CO 80301

United States

Founded in 1999





Key Executives for SomaLogic, Inc.

Chief Executive Officer and Director
Age: 59
Founder and Chairman of the Board
Age: 73
Director of Operations
Chief Medical Officer Emertius
Age: 76
Chief Medical Officer
Age: 55
Compensation as of Fiscal Year 2015.

SomaLogic, Inc. Key Developments

SomaLogic, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 09:40 AM

SomaLogic, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 09:40 AM. Venue: Westin Grand Central, New York, New York, United States.

SomaLogic, Inc. Presents at BIO-Europe 2015, Nov-03-2015 02:00 PM

SomaLogic, Inc. Presents at BIO-Europe 2015, Nov-03-2015 02:00 PM. Venue: Munich, Germany.

SomaLogic and Otsuka Pharmaceutical Extends Initial Collaboration Agreement to Continue the Development of Several Somamer Therapeutics

SomaLogic announced that Otsuka Pharmaceutical has extended its initial collaboration agreement with SomaLogic to continue the development of several SOMAmer therapeutics. Specific projects and financial terms in the extended agreement were not disclosed. SomaLogic is the recognized leader in the development and application of advanced aptamer technologies. The company has designed its proprietary SOMAmer reagents to combine the wide target range of antibodies with the consistency and reproducibility of traditional aptamers. The chemical addition of protein-like side chains to the nucleic acid bases that comprise a SOMAmer molecule results in the ability to discover molecules that bind specifically and tightly to virtually any targeted protein. These properties allow SOMAmer molecules to be used in virtually any laboratory or clinical application that currently uses monoclonal antibodies, including therapeutics. This property, along with other unique characteristics, makes SOMAmer candidates attractive for novel therapeutic discovery and development.

Similar Private Companies By Industry

Company Name Region
Epicentre Technologies Corp. United States
Clintara, LLC United States
Radient Pharmaceuticals Corporation United States
MP Biomedicals, LLC United States
AnaSpec, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SomaLogic, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at